Kent Medical Devices Receives FDA Clearance for Device Detecting Soft Tissue Sites

Kent Medical Devices received Food and Drug Administration clearance for a long-term implantable medical device used for detecting biopsy and soft tissue sites during and after surgical procedures, according to a Medscape Today report.

Advertisement

The device, KMD-Mark1, is made using barium-containing radio-opaque polyaryletherketone polymer, a substance similar to bone. The device radiographically marks the soft tissue areas during spinal and orthopedic procedures. The material has been used in worldwide implants.

Read the Medscape Today report on the Kent Medical device.

Read other coverage on soft tissue technology:

– Shoulder Specialist Dr. Michael Gross Discusses Two Advances in shoulder Surgery

– BioSET Subleases Tissue Repair Technology for Sports Medicine Use

-Anulex Technologies Raises $20M for Soft Tissue Repair Product Development

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.